Small Molecules
3 April 2017
Phase III ALUR study supports the use of Roche’s Alecensa for people with advanced ALK-positive lung cancer30 March 2017
Spero Therapeutics Receives $6.8 Million Award from CARB-X to Combat Antibiotic-Resistant BacteriaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports